Prices of 42 essential medicines used in treatment of various ailments including tuberculosis, cancer, cardiac diseases, asthma, epilepsy and depression have been capped by the government, reducing their cost by up to 15 per cent.
Drug price regulator, National Pharmaceutical Pricing Authority (NPPA), in a notification on its website, said it “has fixed/revised ceiling prices of 45 scheduled formulations of Schedule-I under Drugs (Price Control) Amendment Order, 2016.”
“Out of the 45, the prices of 42 medicines have been reduced by up to 15 per cent,” a official source said.
NPPA said manufacturers not complying with the ceiling price would be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Price Control) Order, 2013.
The authority has also fixed the retail price of 12 formulations under DPCO, 2013.
In another notification, the NPPA said it has also “fixed/revised ceiling prices of 32 scheduled formulations packs of IV Fluids”.
